- AU$3.61m
- AU$2.73m
- AU$1.65m
Annual balance sheet for Biotron, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 7.66 | 4.21 | 1.74 | 3.98 | 0.393 |
| Net Total Receivables | — | — | — | 0.023 | 0.018 |
| Prepaid Expenses | |||||
| Total Current Assets | 7.72 | 4.26 | 1.76 | 4.03 | 0.427 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.073 | 0.031 | 0.09 | 0.05 | 0.013 |
| Long Term Investments | |||||
| Total Assets | 7.83 | 4.33 | 1.91 | 4.14 | 0.493 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 0.841 | 0.451 | 0.751 | 0.956 | 0.738 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.853 | 0.464 | 0.814 | 0.962 | 0.738 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 6.97 | 3.86 | 1.09 | 3.17 | -0.244 |
| Total Liabilities & Shareholders' Equity | 7.83 | 4.33 | 1.91 | 4.14 | 0.493 |
| Total Common Shares Outstanding |